Daptomycin versus Vancomycin in an Enterococcus faecalis Endophthalmitis Rabbit Model

REFERENCES

• Callegan MC, Engelbert M, Parke DW 2nd, Jett BD, Gilmore MS. Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev 2002;15:111–124
   PubMed Web of Science ®Google Scholar
• Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, Kelsey SF. Spectrum and susceptibility of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 1996;122:1–17
   PubMed Web of Science ®Google Scholar
• Gillmore MS, Hoch JA. Antibiotic resistance. A vancomycin surprise. Nature 1999;399:524–525
   PubMed Web of Science ®Google Scholar
• Pathengay A, Moreker MR, Puthussery R, Ambatipudi S, Jalali S, Majji AB, et al. Clinical and microbiological review of culture proven endophthalmitis caused by multidrug resistant bacteria in patients seen at tertiary eye care center in southern India. Retina 2011;31:1806–1811
   PubMed Web of Science ®Google Scholar
• Das MK, Pathengay A, Shah GY, Koday NK. Vancomycin-resistant coagulase negative Staphylococcus endophthalmitis following cataract surgery. J Cataract Refract Surg 2011;37:1908–1909
   PubMed Web of Science ®Google Scholar
• Sharma S, Desai RU, Pass AB. Vancomycin-resistant enterococcal endopthalmitis. Arch Ophthalmol 2010;128:794–795
   PubMed Web of Science ®Google Scholar
• Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC. Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin Infect Dis 2008;46:668–674
   PubMed Web of Science ®Google Scholar
• Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2007;58:163–170
   PubMed Web of Science ®Google Scholar
• Suzuki T, Wada T, Kozai S, Ike Y, Gilmore MS, Ohashi Y. Contribution of secreted proteases to the pathogenesis of postoperative Enterococcus faecalis endophthalmitis. J Cataract Refract Surg 2008;34:1776–1784
   PubMed Web of Science ®Google Scholar
• Silverman JA, Perlmutter NG, Shapiro HM. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother 2003;47:2538–2544
   PubMed Web of Science ®Google Scholar
• Sader HS, Streit JM, Fritsche TR, Jones RN. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002–2004). Clin Microbiol Infect 2006;12:844–852
   PubMed Web of Science ®Google Scholar
• Hawkey PM. Pre-clinical experience with daptomycin. J Antimicrob Chemother 2008;62:7–14
   Web of Science ®Google Scholar
• Mylonakis E, Engelbert M, Qin X, Sifri CD, Murray BE, Ausubel FM, et al. The Enterococcus faecalis fsrB gene, a key component of the fsr quorum-sensing system, is associated with virulence in the rabbit endophthalmitis model. Infect Immun 2002;70:4678–4681
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement M100-S22. Wayne, PA: CLSI; 2012
   Google Scholar
• Pleyer U, Mondino BJ, Adamu SA, Pitchekian-Halabi H, Engstrom RE, Glasgow BJ. Immune response to Staphylococcus epidermidis-induced endophthalmitis in a rabbit model. Invest Ophthalmol Vis Sci 1992;33:2650–2663
   PubMed Web of Science ®Google Scholar
• Peyman GA, Paque JT, Meisels HI, Bennett TO. Postoperative endophthalmitis: a comparison of methods for treatment and prophylaxis with gentamicin. Ophthalmic Surg 1975;6:45–55
   PubMedGoogle Scholar
• Brauers J, Kresken M, Menke A, Orland A, Weiher H, Morrissey I. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations. Int J Antimicrob Agents 2007;29:322–325
   PubMed Web of Science ®Google Scholar
• Rouse MS, Steckelberg JM, Patel R. In vitro activity of ceftobiprole, daptomycin, linezolid, and vancomycin against methicillin-resistant staphylococci associated with endocarditis and bone and joint infection. Diagn Microbiol Infect Dis 2007;58:363–365
   PubMed Web of Science ®Google Scholar
• Tobudic S, Poeppl W, Kratzer C, Vychytil A, Burgmann H. Comparative in vitro antimicrobial activity of vancomycin, teicoplanin, daptomycin and ceftobiprole in four different peritoneal dialysis fluids. Eur J Clin Microbiol Infect Dis 2012;31:1327–1334
   PubMed Web of Science ®Google Scholar
• Leonard SN, Cheung CM, Rybak MJ. Activities of ceftobiprole, linezolid, vancomycin, daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2008;52:2974–2976
   PubMed Web of Science ®Google Scholar
• Comer GM, Miller JB, Schneider EW, Khan NW, Reed DM, Elner VM, Zacks DN. Intravitreal daptomycin: a safety and efficacy study. Retina 2011;31:1199–1206
   PubMed Web of Science ®Google Scholar
• Ozcimen M, Sakarya Y, Ozcimen S, Sakarya R, Goktas S, Iyisoy S, et al. Clearance of intravitreal daptomycin in uveitis induced rabbit model. Curr Eye Res 2014;11:1–6
   Google Scholar
• Lefèvre S, Saleh M, Marcellin L, Subilia A, Bourcier T, Prévost G, Jehl F. Daptomycin versus vancomycin in a methicillin-resistant Staphylococcus aureus endophthalmitis rabbit model: bactericidal effect, safety, and ocular pharmacokinetics. Antimicrob Agents Chemother 2012;56:2485–2492
   PubMed Web of Science ®Google Scholar
• Coskun E, Okumus S, Gurler B, Demir T, Bahar AY, Zer Y, et al. Comparison of intravitreal vancomycin and daptomycin application in experimental methicillin-resistant Staphylococcus aureus (MRSA) endophthalmitis in rabbits. Cutan Ocul Toxicol 2013;32:222–227
   PubMed Web of Science ®Google Scholar
• Domínguez-Herrera J, Docobo-Pérez F, López-Rojas R, Pichardo C, Ruiz-Valderas R, Lepe JA, Pachón J. Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother 2012;56:613–617
   PubMed Web of Science ®Google Scholar
• Belmatoug N, Fantin B. Contribution of animal models of infection for the evaluation of the activity of antimicrobial agents. Int J Antimicrob Agents 1997;9:73–82
   PubMed Web of Science ®Google Scholar
• Giansanti F, Ramazzotti M, Giuntoli M, Virgili G, Vannozzi L, Degl'Innocenti D, Menchini U. Intravitreal infliximab clearance in a rabbit model: different sampling methods and assay techniques. Invest Ophthalmol Vis Sci 2009;50:5328–5335
   PubMed Web of Science ®Google Scholar